Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.

Glanzmann thrombasthenia. Orphanet J Rare Dis (2006) 1.65

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Vasc Health Risk Manag (2007) 0.91

Founder effect and estimation of the age of the French Gypsy mutation associated with Glanzmann thrombasthenia in Manouche families. Eur J Hum Genet (2011) 0.82

The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia. Haematologica (2015) 0.78

The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention. Haematologica (2015) 0.77

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood (2004) 5.10

Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86

Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett (2002) 4.36

Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2010) 3.54

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.41

Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science (2013) 3.33

Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother (2003) 3.22

Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med (2007) 3.18

Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet (2006) 3.17

Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother (2004) 2.89

Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol (2012) 2.38

ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17. Antimicrob Agents Chemother (2002) 2.21

Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood (2006) 2.16

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08

AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.04

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum (2003) 2.03

Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood (2009) 2.03

Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology (2009) 2.00

Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother (2002) 1.94

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood (2009) 1.91

Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol (2005) 1.62

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther (2009) 1.61

Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.58

Hemophilia A induced by ipilimumab. N Engl J Med (2011) 1.55

Acquired hemophilia in older people: a poor prognosis despite intensive care. J Am Geriatr Soc (2007) 1.54

Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol (2004) 1.51

A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet (2010) 1.50

RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family. Antimicrob Agents Chemother (2012) 1.49

Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci U S A (2011) 1.44

The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation (2004) 1.44

Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux. Antimicrob Agents Chemother (2008) 1.44

Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob Agents Chemother (2006) 1.43

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression. Blood (2003) 1.42

Impact of VKORC1 haplotypes on long-term graft function in kidney transplantation. Transplantation (2008) 1.41

Sickle cell disease in Africa. Curr Opin Hematol (2002) 1.41

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation (2005) 1.39

Long-term results of renal transplantation using kidneys harvested from non-heartbeating donors: a 15-year experience. J Urol (2003) 1.39

GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.36

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A. Blood (2005) 1.33

Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) (2012) 1.31

Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood (2008) 1.30

Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood (2006) 1.30

Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation (2010) 1.28

Iliopsoas hematoma in patients with hemophilia: a single-center study. Joint Bone Spine (2007) 1.27

Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci U S A (2004) 1.24

Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene. Antimicrob Agents Chemother (2006) 1.23

Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors. Blood (2005) 1.22

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2005) 1.21

Ribosomal protein S19 expression during erythroid differentiation. Blood (2002) 1.20

Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project. Thromb Haemost (2015) 1.20

Study of the effects of proteasome inhibitors on ribosomal protein S19 (RPS19) mutants, identified in patients with Diamond-Blackfan anemia. Haematologica (2008) 1.16

Integron-associated antibiotic resistance in Salmonella enterica serovar typhi from Asia. Antimicrob Agents Chemother (2003) 1.16

Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation (2003) 1.16

Native valve endocarditis due to Enterococcus hirae. J Clin Microbiol (2002) 1.15

Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis (2011) 1.13

Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet (2004) 1.12

Nonsense-mediated and nonstop decay of ribosomal protein S19 mRNA in Diamond-Blackfan anemia. Hum Mutat (2004) 1.12

Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol (2006) 1.11

Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med (2007) 1.10

Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood (2011) 1.09

Nucleolar localization of RPS19 protein in normal cells and mislocalization due to mutations in the nucleolar localization signals in 2 Diamond-Blackfan anemia patients: potential insights into pathophysiology. Blood (2003) 1.09

Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study. Eur J Haematol (2005) 1.09

An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation (2010) 1.08

Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J Infect Dis (2012) 1.07

Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.07

Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. J Natl Cancer Inst (2011) 1.05

Advances in immunosuppression for renal transplantation. Nat Rev Nephrol (2010) 1.05

Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood (2004) 1.04

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients. Basic Clin Pharmacol Toxicol (2008) 1.03

Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood (2006) 1.02

Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation (2003) 1.02

Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice. Eur J Haematol (2012) 0.98

Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat (2014) 0.97

Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant (2003) 0.97

Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol (2011) 0.97

Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway. Oncogene (2005) 0.95

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2004) 0.95

Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature ("FILS syndrome"). J Exp Med (2012) 0.94

Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A. Blood (2008) 0.93

Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome). Nat Genet (2008) 0.93

Aminoglycoside resistance gene ant(4')-IIb of Pseudomonas aeruginosa BM4492, a clinical isolate from Bulgaria. Antimicrob Agents Chemother (2003) 0.92

Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J Allergy Clin Immunol (2011) 0.92

Surgical prevention and management of vascular complications of kidney transplantation. Transpl Int (2012) 0.91

The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis. FEMS Microbiol Lett (2004) 0.91

von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3. J Clin Invest (2013) 0.91

Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B. J Immunol (2006) 0.91

Ten novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 gene. Hematol J (2003) 0.91

Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. Transplantation (2010) 0.91

Costimulation blockade and its possible future use in clinical transplantation. Transpl Int (2006) 0.91

Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS One (2012) 0.91

Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol (2003) 0.91

Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: a case report and literature review. Nephrol Dial Transplant (2007) 0.90

Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition. Cancer Res (2009) 0.90

Misdiagnosis of chronic thrombocytopenia in childhood. J Pediatr Hematol Oncol (2003) 0.89